Ohr Shuffles Leadership, Names CMO Slakter New CEO

Xconomy New York — 

Jason Slakter has stepped in as the new CEO of Ohr Pharmaceuticals (NASDAQ: OHRP), replacing founder Irach Taraporewala in the head seat of the New York ophthalmics company. Slakter has been Ohr’s chief medical officer since last year, and was the CEO of SKS Ocular—a company Ohr bought in 2014 in a cash-and-stock deal—before that. Taraporewala will now serve as Ohr’s chief technology officer, Ohr said.